Member of the Board of Advisors - ATMPS | Consultant - CSL Behring UK
Following 5 years’ experience working in the gene therapy arena, with a focus on reimbursement and commercialization, Nicola set up NJ Redfern Ltd in 2022 to enable her to consult, coach and collaborate with other organisations, following her departure from bluebird bio in Europe.
With a consistent focus over recent decades on rare disease & oncology/ haematology, her primary attention has been on pricing and reimbursement, service delivery and shaping the external environment. She has been in the pharmaceutical industry since 1989, joining from Martin House Childrens Hospice in Yorkshire, and has been employed by 10 different companies, and contracted with 13 to date, in a diverse range of roles – including supporting 2 further gene therapy companies in their launch planning in the UK. Nicola was previously an active member of the ABPI – chairing the ATMP working group during 2021, a member of their Value and Access group and supporting various government affairs/communications initiatives. She has worked closely in the last 6 years with the Cell and Gene therapy catapult in the UK.
More recently Nicola has been invited to sit on the advisory board for company ATMPS, is an advisor to Hanover Communications team, has given talks at various ATMP congresses, been interviewed by Lumanity and Haemnet, and since January 2023 sits on the ethics subgroup of the International Society of Cell and Gene therapy and is a member of ATMP engage.
Nicola is committed to and motivated by patients having a choice and being able to access transformative treatment options quickly once science and innovation reaches a point to positively impact the lives of people living with significant health challenges. Having sat on the board of trustees at Naomi House and Jacks Place – a Hospice for children and young adults near Winchester, UK – and through working alongside multiple patient organisations over her career, she has a strong empathy and understanding of life limiting conditions and their impact on the individual, their families and society as a whole.
Working with Life Science Access Academy, our company love the variety of the many courses that are on offer. The hour long courses on specific subjects are really useful on Friday lunchtimes for our field teams and gain a lot of interest.
Life Science Access Academy are also super flexible and helpful when it comes to tailoring some additional sessions to our needs.
Frontier Medical has fully implemented, Life Science Access Academy allowing Sales and Marketing to utilise the system. Maximising on line learning for all remote staff stimulates a culture of self-development giving individuals the accountability and responsibility to broaden their skills set.
Life Science Access Academy training is topical and a good fit for the faced paced healthcare market.
I have found the training via the Life Science Access Academy to be excellent and I know many of my colleagues have as well.
The content is always kept up to date and there is huge and interesting variety of topics covered. The site is curated in a way that makes it clear and easy to navigate. Also, the staff at Life Science access Academy are friendly and responsive and all the experts are always knowledgeable in their areas.
The variety and relevancy of content brings value to many different roles across the healthcare industry.
I have also been overwhelmed by the way the Life Science Access Academy team have accommodated our own business needs, being sensitive yet responsive to helping us since its formation.